Exposure to Mebendazole and Pyrvinium during Pregnancy: A Danish Nationwide Cohort Study

<table>The maternal exposure to pyrvinium, mebendazole, and both drugs before, during, and after pregnancy, expressed by seven three-month time frames. For a better overview the data is shown in tables and figures.</table>

Infectious Diseases in Obstetrics and Gynecology

fig1

Figure 1

Figure 1: Exposure to Mebendazole and Pyrvinium during Pregnancy: A Danish Nationwide Cohort Study 